Mebanazine
Mebanazine is a pharmaceutical drug that belongs to the class of antipsychotic medications. It was developed in the mid-20th century and has been used in the treatment of various mental disorders.
History[edit | edit source]
Mebanazine was first synthesized in the 1950s as part of a series of compounds designed to treat psychosis. It was one of the first antipsychotic drugs to be developed, following the discovery of chlorpromazine in the early 1950s.
Pharmacology[edit | edit source]
Mebanazine works by blocking dopamine receptors in the brain. Dopamine is a neurotransmitter that plays a key role in mood, motivation, and reward. By blocking these receptors, Mebanazine can help to reduce the symptoms of psychosis.
Clinical Use[edit | edit source]
Mebanazine has been used in the treatment of a variety of mental disorders, including schizophrenia, bipolar disorder, and severe depression. It is typically used in cases where other treatments have been ineffective.
Side Effects[edit | edit source]
Like all antipsychotic drugs, Mebanazine can cause a range of side effects. These can include drowsiness, dizziness, and blurred vision. In rare cases, it can also cause more serious side effects such as tardive dyskinesia, a condition characterized by involuntary movements of the face and body.
See Also[edit | edit source]
References[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD